Hims vs Noom (2026): Brand-Name vs Compounded GLP-1s

Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a month all-in. Noom Med bundles mainly compounded GLP-1s with its coaching app, from about $179 a month, billed every 12 weeks. Hims is our pick if you want FDA-approved medication; Noom suits people who want coaching and a lower compounded price. Prices checked September 20 and 21, 2026.

Price

Hims charges $39 for the first month of membership, then $149 a month, plus medication, from $298 all-in at starting doses. Noom’s microdose semaglutide plan is $79 for the first 4 weeks, then $537 every 12 weeks, about $179 a month. Full-dose compounded semaglutide is $837 every 12 weeks, about $279 a month. Noom’s brand-name telehealth tier starts at $39, with medication billed separately.

Medications

Hims lists the Wegovy pill and pen, Zepbound, Foundayo, Ozempic and Mounjaro, all FDA-approved. Noom’s main plans use compounded semaglutide or tirzepatide, which Noom says are made in an FDA-registered facility but not reviewed by the FDA for safety, efficacy or quality. Insured patients can use Noom’s tier for brand-name drugs.

Care and support

Hims offers 24/7 messaging with licensed providers, dose adjustments and a peer community. Noom pairs clinician care with its psychology-based coaching app for tracking and behavior change. Noom says its program is not available in all 50 states.

Trust and reviews

Hims rates 2.9 out of 5 on Trustpilot from 9,331 reviews across all its products. We did not verify a Trustpilot rating for Noom Med. Our scores are 6.8 for Hims and 6.4 for Noom Med.

Which should you choose?

Choose Hims if FDA approval matters most and you want monthly billing. Choose Noom if you want structured coaching with a lower compounded price and accept 12-week billing and compounded medication.